A Pfizer Win Against Uncle Sam Could Unleash ‘Gold Rush’ in Sales — and Cost Taxpayers Billions
Three years ago, pharma giant Pfizer paid $24 million to settle federal allegations that it was paying kickbacks and inflating sales by reimbursing Medicare patients ...
